AKEBIA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.4 USD | -6.04% |
|
+11.11% | +12.90% |
| Apr. 23 | Averoa Seeks EU Approval for Chronic Kidney Disease Drug | MT |
| Apr. 16 | Akebia Therapeutics, Inc. and STA Pharmaceutical Hong Kong Limited Enters into Second Amendment to the Supply Agreement | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-02 | 2024-05-03 | 2024-05-06 | 2024-05-07 | |
|---|---|---|---|---|
| Last | 1.3 $ | 1.37 $ | 1.49 $ | 1.4 $ |
| Volume | 2 500 275 | 3 117 001 | 2 336 106 | 4 088 622 |
| Change | +4.84% | +5.38% | +8.76% | -6.04% |
| Opening | 1.26 | 1.34 | 1.41 | 1.51 |
| High | 1.31 | 1.42 | 1.50 | 1.56 |
| Low | 1.22 | 1.32 | 1.40 | 1.38 |
Performance
| 1 day | -6.04% | ||
| 1 week | +11.11% | ||
| Current month | +11.11% | ||
| 1 month | -6.04% | ||
| 3 months | -15.15% | ||
| 6 months | +28.44% | ||
| Current year | +12.90% | ||
| 1 year | +28.44% | ||
| 3 years | -55.13% | ||
| 5 years | -76.94% | ||
| 10 years | -93.92% |
Volumes
marketsDaily volume
4 088 622
Estimated daily volume
4 088 622
Avg. Volume 20 sessions
2 731 530
Daily volume ratio
1.50
Avg. Volume 20 sessions USD
3 824 142.00
Record volume 1
84 387 410
Record volume 2
81 420 240
Record volume 3
81 393 290
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
293 121 185
Net sales (USD)
194 623 000
Number of employees
167
Sales / Employee (USD)
1 165 407
Free-Float
90.33 %
Free-Float capitalization (USD)
265 070 968
Average Daily Capital Traded
1.3%
Highs and lows
1 week
1.22
1.56
1 month
1.221.62
Current year
1.212.48
1 year
0.782.48
3 years
0.244.33
5 years
0.2413.71
10 years
0.2431.00
Indicators
Moving average 5 days
1.36
Moving average 20 days
1.39
Moving average 50 days
1.56
Moving average 100 days
1.50
Price spread / (MMA5)
-2.86%
Price spread / (MMA20)
-0.86%
Price spread / (MMA50)
+11.54%
Price spread / (MMA100)
+7.24%
STIM
RSI 9 days
62.19
RSI 14 days
53.67
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -6.04% | +11.11% | +12.90% | +28.44% | 293M | ||
| +1.18% | +8.90% | +10.44% | +27.28% | 107B | ||
| +1.92% | +4.44% | +0.82% | +17.85% | 106B | ||
| +0.88% | +4.50% | +6.72% | +0.58% | 23.47B | ||
| -2.65% | +2.32% | -13.89% | -16.19% | 21.9B | ||
| +0.40% | +2.84% | -6.64% | -26.33% | 18.77B | ||
| -0.28% | +4.53% | -37.26% | -31.32% | 17.85B | ||
| -1.18% | +4.30% | -10.98% | -35.72% | 16.78B | ||
| +1.04% | +4.11% | +8.67% | +47.01% | 14.41B | ||
| +0.74% | +7.41% | +41.08% | +3.85% | 12.86B | ||
| +1.79% | +0.04% | +327.78% | +248.25% | 8.78B | ||
| +1.61% | +5.14% | -23.57% | -31.35% | 8.37B | ||
| -1.80% | -2.75% | -52.16% | -70.13% | 7.67B | ||
| -0.61% | -1.05% | -0.33% | +29.99% | 7.67B | ||
| +1.48% | -1.78% | +7.96% | +43.97% | 7.77B | ||
| +1.69% | +11.51% | +7.52% | +31.36% | 7.34B | ||
| Average | +0.01% | +4.69% | +17.44% | +16.72% | ||
| Weighted average by Cap. | +0.86% | +5.48% | +8.10% | +14.81% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
a2cc1b2da58417f358fdb3.FYYTE9WCj6iZgPxIYLv6JWksPGtoAY8fajMIg4nACMg.Y8xJdIyyvP3S5ZUCGvTJaThPaQYYMNgrIXhq57C6QphCt1F-m8jk_uzstQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 1.4 | 70,187 | 3,873,914 |
| 03:59:59 pm | 1.39 | 100 | 3,803,727 |
| 03:59:59 pm | 1.39 | 100 | 3,803,627 |
| 03:59:58 pm | 1.39 | 123 | 3,803,527 |
| 03:59:58 pm | 1.39 | 100 | 3,803,404 |
| 03:59:58 pm | 1.39 | 200 | 3,803,304 |
| 03:59:58 pm | 1.39 | 100 | 3,803,104 |
| 03:59:57 pm | 1.39 | 200 | 3,803,004 |
| 03:59:56 pm | 1.39 | 148 | 3,802,804 |
Monthly variations
Annual change
| 2024 | +12.90% | ||
| 2023 | +114.90% | ||
| 2022 | -74.47% | ||
| 2021 | -19.29% | ||
| 2020 | -55.70% | ||
| 2019 | +14.29% | ||
| 2018 | -62.81% | ||
| 2017 | +42.84% | ||
| 2016 | -19.43% | ||
| 2015 | +11.00% | ||
| 2014 | -56.40% |
- Stock Market
- Equities
- AKBA Stock
- Quotes Akebia Therapeutics, Inc.